Article
Committee Opinion No. 640
1 Sept 2015
Abstract excerpt
Noninvasive prenatal screening that uses cell-free DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy. A number of laboratories have validated different techniques for the use of cell-free DNA as a screening test for fetal aneuploidy. All tests have a high sensitivity and specificity for trisomy 18 and trisomy 21, regardless of which molecular technique is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
